Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study
Line J H Rasmussen, Steen Ladelund, Thomas H Haupt, Gertrude E Ellekilde, Jesper Eugen-Olsen, Ove Andersen
Dyk ned i forskningsemnerne om 'Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study'. Sammen danner de et unikt fingeraftryk.